Article
The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.
Clinical and experimental immunology - 1 Oct 2007
Colobran R, Pujol-Borrell R, Armengol M P, Juan M
Abstract excerpt
In this second review on chemokines, we focus on the polymorphisms and alternative splicings and on their consequences in disease. Because chemokines are key mediators in the pathogenesis of inflammatory, autoimmune, vascular and neoplastic disorders, a large number of studies attempting to relate particular polymorphisms of chemokines to given diseases have already been conducted, sometimes with contradictory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
